Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by CancerSlayeron Jun 13, 2024 12:52pm
197 Views
Post# 36087414

RE:RE:RE:RE:And it happened...

RE:RE:RE:RE:And it happened...
plantrader wrote: How would anyone know what to expect anymore? Didn't Dr Mandel say in some interview in late 2022 that they expect to apply for BTD in Jan 2023? That was 1.5 years ago, good grief. Did they not consult in advance, they had no idea what was required or how the process works? Then again, I'm sure they were juggling a thousand things at the same time perpetually. Small, low on funds minimally staffed company and all.



"I'm sure they were juggling a thousand things at the same time perpetually. Small, low on funds minimally staffed company and all."

Those are good reasons...The FDA's request for central path lab review was probably the biggest hiccup...not sure when it first knowingly became one.  Maybe someone else does....
<< Previous
Bullboard Posts
Next >>